Healthcare Industry News: Allergan
News Release - November 4, 2010
Bausch & Lomb Surgical Strengthens Management Team With Three New AppointmentsALISO VIEJO, CA--(Healthcare Sales & Marketing Network) - Bausch & Lomb, the global eye health company, has appointed three industry veterans to key management roles in its Surgical business.
Brad Paddock has been hired as vice president, Sales; Anthony Sine is appointed vice president, Business Development; and Elisabeth Sandoval is named vice president, Global Marketing.
"These three management appointments will immediately strengthen and positively impact our Surgical business for the benefit of our customers worldwide," said Robert Grant, CEO and president, Bausch & Lomb Surgical. "With their knowledge, insights and demonstrated track record of success, they'll complement our existing global leadership team."
Mr. Paddock began his career at Ethicon (Johnson & Johnson), quickly becoming a top sales representative. He then joined Kyphon Inc., where he held sales management positions of increasing responsibility, leading the sales team for 35 quarters of consecutive growth. He was the company's vice president of sales from 2004 until 2008, when it was acquired by Medtronic.
Mr. Sine began his career as an associate with Brobeck, Phleger and Harrison working primarily on venture capital financings and dispositions. He then moved to Greenberg Traurig where he focused on private equity, followed by a role at Latham & Watkins where he participated in a broad range of acquisition and licensing activities. Mr. Sine was most recently senior corporate counsel and assistant secretary at Allergan, Inc., where he completed over 15 M&A and licensing transactions.
Ms. Sandoval has more than 25 years of pharmaceutical and device experience. She began her career with Ethicon (Johnson & Johnson) in research and development. She then joined Allergan, moving from R&D into sales and marketing roles that spanned over 20 years. Ms. Sandoval was most recently vice president of Global Strategic Marketing for Allergan Medical, where she drove the launch of the market-leading Juvederm dermal filler and established the company's worldwide marketing team.
The three executives will be based at the company's Surgical business center in Aliso Viejo, Calif.
About Bausch & Lomb
Bausch & Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch & Lomb name is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.
Source: Bausch & Lomb
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.
Related News ItemsBausch & Lomb Announces the U.S. Launch of LOTEMAX(R) SM (Loteprednol Etabonate Ophthalmic Gel) 0.38% for the Treatment of Postoperative Inflammation and Pain Following Ocular Surgery
Bausch & Lomb Receives 510(k) Clearance For Use Of The Tangible(R) Hydra-PEG(R) Custom Contact Lens Coating Technology On Several Of Its Boston(R) Gas Permeable Lens Materials And Zenlens(TM) Family Of Scleral Lenses
Synergy Pharmaceuticals Announces Agreement for Bausch Health to Acquire Its Business Assets